Search

Your search keyword '"Pierre Gallian"' showing total 4 results
Start Over Author "Pierre Gallian" Journal vox sanguinis
4 results on '"Pierre Gallian"'

1. International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

Author

Richard Gammon, Pierre Gallian, J. N. S. Leung, David J. Roberts, Karin van den Berg, James Daly, Robby Nur Aditya, Michel Toungouz Nevessignsky, Rekha Hans, Paula Verónica Cini, Pierre Tiberghien, Levent Sagdur, Nil Banu Pelit, Gopal Kumar Patidar, Nancy M. Dunbar, Eilat Shinar, Ivan Hung, Carlos Alberto Gonzalez, Richard Schäfer, Rita A. Reik, Hua Xu, Ru Yang, Khuloud Al Maamari, Salwa Hindawi, Naomi Rahimi-Levene, Patricia Scuracchio, Rahul Chaurasia, Sinyoung Kim, Marion Vermeulen, Hans Vrielink, Lise Sofie H. Nissen-Meyer, Mark H. Yazer, Melissa Lopez, Jarkko Ihalainen, Silvano Wendel, Vincenzo De Angelis, Pampee P. Young, Ratti Ram Sharma, Cynthia So-Osman, Antti Vierikko, Hem Chandra Pandey, Ai Leen Ang, Yan Qiu, Angelo Ostuni, Renée Bazin, Cheuk-Kwong Lee, Giuseppe Marano, Zaid Al-Hinai, Roberta Fachini, Pascal Morel, Marina Izak, Lise J Estcourt, Pierluigi Berti, Tanya Nadia Glatt, David Martin Ferrari, Thierry Burnouf, Veronica C. Hoad, Maha A. Badawi, Levent Tufan Kumaş, Magdy El Ekiaby, Vernon J. Louw, Darrell J. Triulzi, Arwa Z. Al-Riyami, Divjot Singh Lamba, Suchet Sachdev, Kiat Hoe Ong, Dana V. Devine, Sheila Maclennan, and Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille)

Subjects
0303 health sciences, 2019-20 coronavirus outbreak, Convalescent plasma, Coronavirus disease 2019 (COVID-19), business.industry, [SDV]Life Sciences [q-bio], Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Hematology, General Medicine, 030204 cardiovascular system & hematology, Virology, 03 medical and health sciences, 0302 clinical medicine, Medicine, International Forum, business, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology
Abstract

International audience

Published
2021

2. International Forum on Occult hepatitis B infection and transfusion safety

Author

Kate I Tettmar, Jun Nyun Kim, Sylvie Gross, Erhard Seifried, Padraig Williams, Fiona Boland, Aneta Kopacz, Louise Pomeroy, Magdy El Ekiaby, Pierre Gallian, Patricia E. Hewitt, Marta Bes, W. C. Tsoi, Sze Sze Chua, Eun Young Oh, Niamh O'Flaherty, Miquel Lozano, Roberta Fachini, Veronica C. Hoad, Michael Schmidt, Maria Piron, Richard Charlewood, Rikizo Taira, Lisa Jarvis, Clive R. Seed, Patricia Carminato, Philip Kiely, Jean-Pierre Allain, Silvia Sauleda, Sheila F. O'Brien, Magdalena Łętowska, Margaret Fearon, Syria Laperche, Ai Leen Ang, Sally Lam, Peter Flanagan, Snežna Levičnik Stezinar, Susan L. Stramer, Patricia Scuracchio, S. Wendel, Marion Vermeulen, Masahiro Satake, K. L. Davison, Polona Nograšek, Giles Delages, Piotr Grabarczyk, Juraj Petrik, Keiji Matsubayashi, So-Yong Kwon, Division of Transfusion Medicine, University of Cambridge [UK] (CAM), 1National Institute of Blood Transfusion (INTS) - Department of Blood-borne agents, National Reference Center for Hepatitis B and C and HIV in Transfusion, Etablissement Français du Sang - Alpes-Méditerranée (EFS - Alpes-Méditerranée), Etablissement Français du Sang, Etablissement Français du Sang [La Plaine Saint-Denis] (EFS), Groupe de Recherche sur le Handicap Ventilatoire (GRHV), Institute for Research and Innovation in Biomedicine (IRIB), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-CHU Rouen, Normandie Université (NU), Institute for Study of Earth, Oceans and Space, University of New Hampshire (UNH), Scottish National Blood Transfusion Service, Department of Immunohaematology, Institute of Haematology and Transfusion Medicine, Institute for Transfusion Medicine and Immunohaematology [Frankfurt/Main], Goethe-Universität Frankfurt am Main, and Dept. of Cellular Therapeutics / Cell Processing (GMP)

Subjects
medicine.medical_specialty, business.industry, [SDV]Life Sciences [q-bio], MEDLINE, Occult hepatitis B infection, Hematology, General Medicine, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2019

3. Hepatitis E

Author

Juraj Petrik, Miguel Lozano, Clive R. Seed, Helen M. Faddy, Anthony J. Keller, Patricia Santos Prado Scuracchio, Silvano Wendel, Anton Andonov, Margaret Fearon, Gilles Delage, Jun Zhang, James Wai Kuo Shih, Pierre Gallian, Rachid Djoudi, Pierre Tiberghien, Jacques Izopet, Jens Dreier, Tanja Vollmer, Cornelius Knabbe, Rakesh Aggarwal, Amit Goel, Anna Rita Ciccaglione, Keiji Matsubayashi, Masahiro Satake, Kenji Tadokoro, Sook-Hyang Jeong, Hans L. Zaaijer, Eugene Zhiburt, Jason Chay, Diana Teo, Sze Sze Chua, Maria Piron, Silvia Sauleda, José-Manuel Echevarría, Harry Dalton, Susan L. Stramer, Scottish National Blood Transfusion Service, Department of Hemotherapy and Hemostasis, University Clinical Hospital, School of Environmental and Life Sciences, Newcastle University [Newcastle], Institute for Study of Earth, Oceans and Space, University of New Hampshire (UNH), Laboratory of Microbiology, Wageningen University and Research [Wageningen] (WUR), Etablissement Français du Sang - Alpes-Méditerranée (EFS - Alpes-Méditerranée), Etablissement Français du Sang, Emergence des Pathologies Virales (EPV), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Department of Laboratory Medicine and Molecular Diagnostics, Robert-Bosch-Hospital, Centro Nacional de Microbiología, Instituto de Salud Carlos III [Madrid] (ISC), European Centre for Environment and Human Health, Royal Cornwall Hospital-Plymouth University, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté]), Royal Cornwall Hospital-Universities of Exeter and Plymouth, Landsteiner Laboratory, Medical Microbiology and Infection Prevention, AII - Infectious diseases, and AII - Amsterdam institute for Infection and Immunity

Subjects
[SDV]Life Sciences [q-bio], Hematology, General Medicine, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2015

4. Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria

Author

Pierre Gallian, P. Guntz, Tamer Abdelrahman, A. Assal, P. Volle, M.-H. Elghouzzi, S. Berrebi, Ermanno Candolfi, Valérie Barlet, Alexandre Senegas, M. Beolet, C. Doderer, D. Filisetti, C. Chuteau, and T. Steinmetz

Subjects
Blood transfusion, Concordance, medicine.medical_treatment, Plasmodium falciparum, Plasmodium vivax, Antibodies, Protozoan, Fluorescent Antibody Technique, Blood Donors, Enzyme-Linked Immunosorbent Assay, Immunofluorescence, law.invention, law, parasitic diseases, medicine, Animals, Humans, Mass Screening, Prospective Studies, Polymerase chain reaction, Retrospective Studies, biology, medicine.diagnostic_test, business.industry, Reproducibility of Results, Hematology, General Medicine, biology.organism_classification, medicine.disease, Virology, Malaria, Immunology, biology.protein, Blood Banks, France, Antibody, business
Abstract

The risk of malaria transmission by blood transfusion is critical due to extensive travel from endemic areas to non-endemic areas. An enzyme-linked immunosorbent assay (ELISA) malaria antibody test has been developed that is claimed to perform better than the immunofluorescence assay test (IFAT). The assay contains antigens to both Plasmodium falciparum and Plasmodium vivax. A multicentre study was performed to evaluate the appropriateness of replacing the IFAT by the new ELISA test. Nine French blood banks participated in this multicentre study. Two panels of samples were evaluated. The first included 4163 samples from healthy donors and was used to calculate clinical specificity of the assay. The second involved 10 995 samples either collected retrospectively or prospectively from malaria-risk donors was used to assess the comparative performance of the ELISA and IFAT. Discordant samples were further tested using an in-house IFAT and also tested for presence of Plasmodium DNA by polymerase chain reaction. The ELISA showed a clinical specificity of 99.02%. In the malaria-risk blood donors groups the retrospective group showed a concordance rate of 92.6% (k = 0.90) while the prospective group showed a concordance rate of 97% (k = 0.46). After confirming the discordant sample results by an in-house IFAT the k index increased to 0.81. None of the discordant samples was shown to contain Plasmodium DNA. The performance of the ELISA test in this study has confirmed its potential as a new screening test for use in blood banks as an alternative to the IFAT in prevention of transfusion-transmitted malaria in non-endemic countries. (authors)

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results